Alkermes plc - Ordinary Shares (ALKS): Price and Financial Metrics

ALKS POWR Grades

• Value is the dimension where ALKS ranks best; there it ranks ahead of 98.64% of US stocks.
• The strongest trend for ALKS is in Stability, which has been heading down over the past 177 days.
• ALKS ranks lowest in Stability; there it ranks in the 14th percentile.

ALKS Stock Summary

• ALKERMES PLC's stock had its IPO on July 16, 1991, making it an older stock than 84.05% of US equities in our set.
• Over the past twelve months, ALKS has reported earnings growth of -277.65%, putting it ahead of just 4.64% of US stocks in our set.
• As for revenue growth, note that ALKS's revenue has grown 40.56% over the past 12 months; that beats the revenue growth of 88.6% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to ALKERMES PLC are ATEN, MDRX, AXTI, VNDA, and LAW.
• ALKS's SEC filings can be seen here. And to visit ALKERMES PLC's official web site, go to www.alkermes.com.

ALKS Valuation Summary

• In comparison to the median Healthcare stock, ALKS's price/earnings ratio is 29.19% lower, now standing at 18.8.
• ALKS's price/earnings ratio has moved up 41.5 over the prior 243 months.

Below are key valuation metrics over time for ALKS.

ALKS Growth Metrics

Its 3 year net income to common stockholders growth rate is now at 64.4%.
• Its 4 year revenue growth rate is now at 52.95%.
• Its 3 year cash and equivalents growth rate is now at 25.45%.

Over the past 34 months, ALKS's revenue has gone down $82,270,000.

The table below shows ALKS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	1,111.795	21.044	-158.267
2022-09-30	1,131.584	51.018	-129.14
2022-06-30	1,173.368	133.17	-94.154
2022-03-31	1,200.866	168.539	-61.654
2021-12-31	1,173.751	101.715	-48.169
2021-09-30	1,129.283	138.037	-91.684

ALKS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ALKS has a Quality Grade of B, ranking ahead of 88.71% of graded US stocks.
• ALKS's asset turnover comes in at 0.582 -- ranking 63rd of 680 Pharmaceutical Products stocks.
• OTLK, AVEO, and LXRX are the stocks whose asset turnover ratios are most correlated with ALKS.

The table below shows ALKS's key quality metrics over time.